Familial myopathy: new insights into the T14709C mitochondrial tRNA mutation
| Autor: | Patrick F. Chinnery, Stephen Lynn, Douglass M. Turnbull, Robert W. Taylor, C Hayes, Julie L. Gardner, Mark Walker, Martin J. Barron, Robert McFarland, Andrew M. Schaefer |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Adult
Male Mitochondrial DNA Adolescent RNA Mitochondrial Biology Cytosine Mitochondrial myopathy medicine Humans Myopathy Muscle Skeletal Gene Cells Cultured Genetics Homoplasmy Histocytochemistry Mitochondrial Myopathies Sequence Analysis DNA Fibroblasts Middle Aged medicine.disease Phenotype Heteroplasmy RNA Transfer Glu Pedigree Neurology Protein Biosynthesis Mutation (genetic algorithm) Mutation RNA Female Neurology (clinical) medicine.symptom Thymine |
| Zdroj: | Annals of neurology. 55(4) |
| ISSN: | 0364-5134 |
| Popis: | We have defined the genetic defect in a large family first described in one of the earliest reports of suspected mitochondrial myopathy, as the mutation T14709C in the mitochondrial transfer RNA(Glu) (mt-tRNA(Glu)) gene. Extraordinarily, this mutation has attained homoplasmy (100% mutated mt-tRNA(Glu)) on at least three independent occasions in this family and has done so in one individual who remains asymptomatic with no clinical evidence of disease. Heteroplasmy (dual populations of mutated and wild-type mtDNA) usually is regarded as one of the primary diagnostic criteria for pathogenicity and previous reports of the T14709C mutation detail heteroplasmy in a variety of tissues. In contrast, homoplasmy of mt-tRNA mutations generally has been regarded as evidence of a benign nature, with rare exceptions that result in organ-specific phenotypes. Discovering that T14709C, a common and severe mt-tRNA mutation, can attain homoplasmy without symptoms or clinical signs of disease has profound implications for the identification and prevalence of other pathogenic mt-tRNA mutations. Furthermore, variation in phenotype between homoplasmic individuals implies a crucial contribution from the nuclear genetic environment in determining the clinical outcome of mt-tRNA mutations. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text